Skip to main content
All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for LUNDBECK PHARMACEUTICALS LLC · Specialty and Central Nervous System Bio-pharmaceutical manufacturing.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $40,000.00 income · posted Apr 18, 2025

Official filing document

 Lobbying activity 2
Health Issues

Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._Modernizing and Ensuring PBM Accountability Act.

Medicare/Medicaid

Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem